- Dr. rer. nat. Andreas Hartlep
Chief Executive OfficerDr. Hartlep is CEO at cerbomed GmbH since in April 2010. He joined cerbomed in 2009 as CTO. He has over 12 years experience in leadership and senior management roles in medical device technology, R&D and clinical operations including the development of IGS and robotic products. Prior to his last position as Executive Director R&D for Prosurgics, Wycombe, UK, a Start-Up company specializing in image-guided surgical robotics, Dr. Hartlep was Director Clinical Operations with Timaq Medical Imaging, Zurich, Switzerland, an innovative clinical trial service company specializing in imaging aspects for both pharmaceutical and medical device companies. Before this, Dr. Hartlep had spent several years with Brainlab Inc., Munich, Germany, where he took increasing responsibilities as Project Manager, Senior Project Manager and Research Director mainly in the areas of neuroscience and imaging. Dr. Hartlep holds a degree in Physics and Medical Physics from the University of Heidelberg, Germany, and acquired his Ph.D. with the German Cancer Research Institut (DKFZ) in Heidelberg, Germany.
- Prof. Dr. med. Jens Ellrich
Chief Medical OfficerProf. Dr. Ellrich is Chief Medical Officer at cerbomed GmbH since August 2010. He brings a wealth of experience for his new task as CMO, having spent 20 years in the field of neuroscience. Further he is professor of medical physiology at the University of Aalborg in Denmark.
At the University of Aalborg Prof. Dr. Ellrich was head of the "Medical Physiology and Experimental Pharmacology Group". Prior to that, he was professor of experimental neurosurgery at the Interdisciplinary Center for Clinical Research at the RWTH Aachen University for more than four years and supervised the new neuroscientific research group "Pain". His research focuses on the interface between basic research and its clinical application, especially in terms of neuromodulation and the plasticity of neural signal processing. He has published more than 70 original papers in scientific journals with peer review.
He started his scientific career with a PhD in the department of Neurology and Clinical Neurophysiology at the University of Mainz. In 2000 he obtained his postdoctoral lecture qualification at the Physiology and Experimental Pathophysiology Institute of the University of Erlangen-Nuremberg.
Recently, he has become a member of the Medical Faculty of the Friedrich-Alexander-University Erlangen-Nuremberg.
- Dr. Robert Pfeffer
Chief Financial OfficerDr. Pfeffer is Head of Finance at cerbomed GmbH since October 2008. He began his 10 years banking career in internal traineeships with the Sparkasse Finanzgruppe in Erlangen as well as the Bayrische Landesbank (BayernLB) in New York focusing on Corporate Finance and Internal Audit. After several years of Corporate Client Consultant, he specialized during five years in consulting Start Up companies and managed them through different stages of their development. For many years, he also acted as member of several juries for Start-Up and Entrepreneurship competitions. Dr. Pfeffer holds a degree in Business Administration as well as in Economics, and a PhD.
- Thomas Zschaeck
Director Research & DevelopmentThomas Zschaeck joined cerbomed in early 2012. He has over 20 years experience in the telecommunications industries, working at Philips Kommunikations Industrie and Lucent Technologies. He held several positions in all technical areas – development of complex electronics, manufacturing and production and materials management. For more than 10 years Mr. Zschaeck is working in the field of medical devices. Prior to cerbomed he was quality manager of an innovative medium-sized company based in the Nuremberg area, being responsible for all product and company certifications, regulatory topics and technical specifications for internal and external partners. He is named as an inventor on 3 patents. Thomas Zschaeck holds a masters degree in Electrical Engineering.
- Dr. med. Martin Hyca
Director Marketing & SalesDr. Hyca joined cerbomed in February 2010. After his position as a physician at the German Heart Center in Munich he worked in a health care consultancy (HWP Planungsgesellschaft, Stuttgart) and has now more than 8 years experience in the medical device industry. Prior to his current job Dr. Hyca faced different positions as marketing and product manager at TomTec Imaging Systems, the market leader in 3D ultrasound imaging. As program manager he took over responsibilities in planning and leading innovation projects in the field of medical software development. Furthermore he set up a new product division (MR-imaging) and designed and implemented a new marketing oriented evaluation method for ideas and projects. Dr. Hyca holds degrees in Business Administration (MBA, focus: marketing & sales) and Medical Engineering (MSc) and received his MD and PhD in Medicine from the Ruhr University Bochum.
t-VNS provides advantages for patients. There are no surgical risks and there are only minor side effects. As patients use NEMOS autonomously, the therapy can be easily integrated into the daily routine.
Dr. Andreas Hartlep (CEO)
Do you have questions regarding NEMOS® and t-VNS® therapy? Please get in touch with us.